Latest News about BMY
Recent news which mentions BMY
Bristol-Myers Squibb Unusual Options Activity For February 01
February 01, 2023
Tickers
BMY
From Benzinga
Prothena Touts Encouraging Data From Early-Stage Alzheimer's Candidate
February 01, 2023
From Benzinga
Down 14.5%, Is Pfizer Stock a Screaming Buy?
January 30, 2023
From Motley Fool
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
January 29, 2023
From Benzinga
2 Top Dividend Stocks to Buy in 2023 and Hold Forever
January 29, 2023
From Motley Fool
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
January 27, 2023
From Motley Fool
3 Buffett-Type Stocks to Buy Right Now
January 25, 2023
From Motley Fool
5 Stocks You Can Confidently Invest $500 in Right Now
January 19, 2023
From Motley Fool
Neurodegenerative Diseases Focused Company Goes Public Via Wilbur Ross-Backed SPAC, Joins Alzheimer's Race To Compete Biogen
January 18, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023
January 17, 2023
From Benzinga
Tickers
BMY
From Motley Fool
Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns
January 13, 2023
From MarketWatch
7 Dividend-Paying Large-Cap Stocks to Buy in January
January 13, 2023
From InvestorPlace
From Motley Fool
Is Alexandria Real Estate Equity a Buy?
January 10, 2023
From Motley Fool
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
January 06, 2023
From InvestorPlace
Century Therapeutics Announces Internal Portfolio Prioritization, Analyst Views It As Incrementally Positive
January 06, 2023
From Benzinga
Looking At Bristol-Myers Squibb's Recent Unusual Options Activity
January 05, 2023
Tickers
BMY
From Benzinga
Investors Should Consider This Warren Buffett Advice in 2023
January 04, 2023
From Motley Fool
20 Recession-Proof Stocks to Buy Now for 2023
January 04, 2023
From Motley Fool
Congressman Sells Stocks At End Of 2022 And Retires From Office: Taking Profits Or Warning Sign?
January 03, 2023
From Benzinga
What 6 Analyst Ratings Have To Say About Bristol-Myers Squibb
January 03, 2023
Tickers
BMY
From Benzinga
23 Top Dividend Stocks to Buy and Hold in 2023
January 03, 2023
From Motley Fool
Is Exelixis Stock a Buy Now?
December 29, 2022
From Motley Fool
See a Recession in 2023? Stock Up on These 3 Ultra-Safe Dividend Stocks.
December 24, 2022
From Motley Fool
You Can Boost Your Passive Income With These 3 Dividend Raises
December 23, 2022
From Motley Fool
The Top Healthcare Stocks to Buy With $100
December 22, 2022
From Motley Fool
10 Top Dividend Stocks To Buy For 2023
December 20, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.